Evidence map›Paper›PMID 36010237›Full record

ArticleDiagnostics (Basel, Switzerland)2022

A Unique Observation of a Patient with Vulto-van Silfhout-de Vries Syndrome.

Natalia Bodunova, Maria Vorontsova, Igor Khatkov, Elena Baranova, Svetlana Bykova, Daniil Degterev, Maria Litvinova, Airat Bilyalov, Maria Makarova, Olesya Sagaydak and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Natalia BodunovaThe Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
Maria VorontsovaNational Medical Research Center for Endocrinology, 117292 Moscow, Russia.ORCID 0000-0002-9124-294X
Igor KhatkovThe Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
Elena BaranovaLLC Evogen, 115191 Moscow, Russia.
Svetlana BykovaThe Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
Daniil DegterevThe Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
Maria LitvinovaThe Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
Airat BilyalovThe Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0002-8888-8395
Maria MakarovaLLC Evogen, 115191 Moscow, Russia.
Olesya SagaydakLLC Evogen, 115191 Moscow, Russia.ORCID 0000-0002-2534-8463
Anastasia DanishevichThe Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.
Moscow Clinical Scientific Center · RUKazan Federal University · RURussian Medical Academy of Continuous Professional Education · RUSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vulto-van Silfhout-de Vries Syndrome (VSVS; OMIM#615828) is a rare hereditary disease associated with impaired intellectual development and speech, delayed psychomotor development, and behavioral anomalies, including autistic behavioral traits and poor eye contact. To date, 27 patients with VSVS have been reported in the literature. Materials and Methods: We describe a 23-year-old male patient with autism spectrum disorder (ASD) who was admitted to the gastroenterological hospital with signs of pseudomembranous colitis. ASD was first noted in the patient at the age of 2.5 years. Later, he developed epileptic seizures and important growth retardation. Prior to the hospitalization, chromosomal aberrations, Fragile X syndrome, and aminoacidopathies/aminoacidurias associated with ASD were excluded. Whole-genome sequencing (WGS) was prescribed to the patient at 23 years old. Results: The patient had a heterozygous carrier of “de novo” variant c.662C > T (p.S221L) in exon 4 of the DEAF1 gene. c.662C > T had not been previously described in genomic databases. According to the ACMG criteria, this missense variant was considered to be pathogenic. VSVS was diagnosed in the patient. Conclusions: The phenotype of the patient is very similar to the data presented in the world literature. However, growth retardation and cachexia, which have not been described previously in the articles, are of interest.

Indexed as

DEAF1VSVSVULTO-VAN syndrome

Identifiers

PMID36010237
PMCPMC9406734
OpenAlexW4289985694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.